Concepedia

Jurij Stekar

JS

13

Publications

1.1K

Citations

13

H-Index

1968

Active since

Affiliations

Astellas Pharma (Japan)(Current)

Hochschule Bielefeld

Jurij Stekar is an author at Astellas Pharma (Japan) specializing in pharmacology, medicine, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryToxicologyNatural SciencesOxidative StressMedicinal ChemistryDrug DiscoveryMedical ToxicologyRedox Biology

Publications per year

1968–2015

13

Publications

13

Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.

N Brock, Jurij Stekar, J. Pohl et al. · PubMed · 1979 · 187 citations

Non-toxic Additive Compound, Pharmacotherapy, Urotoxic Side-effects +19

D-21266, a new heterocyclic alkylphospholipid with antitumour activity

P. Hilgard, T. Klenner, Jurij Stekar et al. · European Journal of Cancer · 1997 · 134 citations

Biochemistry, Medicine, Anti-cancer Agent +3

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)

N Brock, Jörg Pohl, Jurij Stekar et al. · European Journal of Cancer and Clinical Oncology · 1982 · 128 citations

Medicinal Chemistry, Biochemistry, Medicine +12

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention

N Brock, Jörg Pohl, Jurij Stekar · European Journal of Cancer and Clinical Oncology · 1981 · 112 citations

Biochemistry, Medicine, Forensic Toxicology +7

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—I

N Brock, Jörg Pohl, Jurij Stekar · European Journal of Cancer (1965) · 1981 · 111 citations

Medicinal Chemistry, Biochemistry, Medicine +8

Rows per page

1–5 of 13